GWM
MBIO icon

Geneos Wealth Management’s Mustang Bio MBIO Stock Holding History

Geneos Wealth Management’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1
Closed – – 2704
2022
Q1 		$0 Hold
1
– – ﹤0.01% 2888
2021
Q4 		$1K Hold
1
– – ﹤0.01% 2689
2021
Q3 		$1K Hold
1
– – ﹤0.01% 2764
2021
Q2 		$2K Hold
1
– – ﹤0.01% 2670
2021
Q1 		$2K Hold
1
– – ﹤0.01% 2903
2020
Q4 		$2K Sell
1
-3
-75% -$7.17K ﹤0.01% 2706
2020
Q3 		$10K Hold
4
– – ﹤0.01% 1948
2020
Q2 		$10K Hold
4
– – ﹤0.01% 1916
2020
Q1 		$8K Hold
4
– – ﹤0.01% 1894
2019
Q4 		$12K Hold
4
– – ﹤0.01% 1895
2019
Q3 		$11K Hold
4
– – ﹤0.01% 1862
2019
Q2 		$12K Hold
4
– – ﹤0.01% 1842
2019
Q1 		$11K Buy
+4
New +$11.3K ﹤0.01% 1809

Other funds holding MBIO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Geneos Wealth Management's MBIO Position: Q2 2022 in Review

Geneos Wealth Management sold out of Mustang Bio (MBIO) in Q2 2022, closing a stake of 1 share.

Geneos Wealth Management first reported a position in MBIO in Q1 2019 and held it in 13 quarters. The position peaked at $12K in Q4 2019. 71 funds tracked by Wall St. Rank hold MBIO as of Q2 2022.

  • Geneos Wealth Management reported no remaining Mustang Bio position as of Q2 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 1 Mustang Bio share in Q2 2022.
  • Geneos Wealth Management first reported a position in Mustang Bio in Q1 2019 and held it in 13 quarters.
  • Geneos Wealth Management's Mustang Bio position peaked at $12K in Q4 2019.
  • 71 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2022.

Based on Geneos Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.